Post-inflammatory hyperpigmentation (PIH) is treatable with topical products, professional procedures, and consistent sun protection. Most cases involving the outer layer of skin respond well within a few months, though deeper pigmentation can take significantly longer. The key is starting treatment early and addressing whatever caused the inflammation in the first place.
What Causes Those Dark Spots
PIH happens when skin inflammation triggers your pigment-producing cells to go into overdrive. Acne breakouts, eczema flares, cuts, burns, and even aggressive skin treatments can all set it off. The inflammation releases signaling molecules that tell your melanocytes to pump out extra melanin, which then spreads into surrounding skin cells.
Where that excess melanin ends up matters a lot for treatment. If it stays in the epidermis (the outer skin layer), the spots look tan to dark brown and typically respond well to topical treatments. If pigment drops deeper into the dermis, the spots take on a blue-gray tone and can be permanent without intervention. A dermatologist can often tell the difference just by looking, or by using a Wood’s lamp.
Treat the Underlying Cause First
This step is easy to overlook, but it’s critical. If you’re still breaking out with acne or dealing with active eczema, new dark spots will keep forming even as you fade the old ones. Getting the original inflammatory condition under control is the foundation of any PIH treatment plan. Once the trigger is managed, the hyperpigmentation itself can be addressed layer by layer.
Topical Treatments That Work
Hydroquinone remains the most established topical treatment for PIH. It works by blocking the enzyme responsible for melanin production. Over-the-counter products contain 2% hydroquinone, while prescription formulas go up to 4%. Most people see noticeable improvement within 4 to 6 weeks, with results plateauing around 4 months. Continuous use beyond 4 to 6 months is generally not recommended because prolonged application (especially over years) carries a small risk of a paradoxical darkening condition called exogenous ochronosis. A systematic review found that ochronosis typically appeared after a median of 5 years of use, but dermatologists still prefer to cycle patients off after a few months as a precaution.
For a more aggressive prescription approach, the modified Kligman formula combines 4% hydroquinone with a retinoid and a mild steroid. This FDA-approved combination attacks pigmentation from multiple angles: the hydroquinone suppresses new melanin, the retinoid speeds up cell turnover to shed pigmented skin faster, and the steroid reduces inflammation that could worsen the problem. It’s effective but requires monitoring because of the steroid component.
If you want to avoid hydroquinone, several alternatives have good evidence behind them. Azelaic acid at 15% to 20% concentration has been shown to significantly improve acne-related PIH with twice-daily use over 12 weeks. It works more gently, which makes it a solid option for sensitive skin or for long-term maintenance. Tranexamic acid, applied topically at 2% to 5%, performs comparably to azelaic acid in clinical trials. Other options include vitamin C serums, niacinamide, kojic acid, and arbutin, all of which interfere with melanin production through slightly different pathways. These can be used alone or layered together for a cumulative effect.
Chemical Peels for Stubborn Spots
Chemical peels accelerate the removal of pigmented skin cells by dissolving the outermost layers. For PIH, superficial peels are the safest starting point, especially for darker skin tones. Options include glycolic acid (20% to 70%), salicylic acid (20% to 30%), lactic acid, and Jessner’s solution. Because they only penetrate the epidermis, superficial peels can be used across nearly all skin types with low risk.
Spot treatment of individual dark marks is also an option, using slightly stronger concentrations of trichloroacetic acid (TCA) at 25% or salicylic acid applied only to the affected areas. Medium-depth peels should be approached cautiously in people with darker complexions (Fitzpatrick skin types IV through VI), since the peel itself can trigger new PIH. Deep peels are not recommended for most dark-skinned individuals due to the risk of permanent pigment changes. If you have a darker skin tone, working with a provider experienced in treating skin of color is especially important.
Laser and Light-Based Options
Lasers can target pigment directly, but they need to be used carefully to avoid triggering more inflammation. Low-fluence Q-switched Nd:YAG laser toning at a wavelength of 1064 nm has shown promise because it causes minimal disruption to the outer skin. Treatment protocols typically involve weekly sessions for about four consecutive weeks, with multiple gentle passes over the skin during each session.
Not all lasers are equal here. Research comparing the Nd:YAG approach with a ruby laser (694.3 nm) found that the ruby laser caused considerably more tissue damage and a greater inflammatory reaction, which could actually create new PIH. This is why laser choice and settings matter enormously. Aggressive lasers that work well on lighter skin can backfire on darker skin tones by causing the very problem you’re trying to fix.
Why Sunscreen Alone Isn’t Enough
Sun protection is non-negotiable during PIH treatment. UV exposure stimulates melanin production and can darken existing spots, undoing weeks of progress. But standard sunscreen has a blind spot: visible light.
Visible light (the 400 to 700 nm range) makes up about 45% of solar radiation and contributes to skin darkening, particularly in people with medium to dark skin tones (Fitzpatrick III and higher). Most sunscreens, even mineral formulas with high SPF, provide limited protection against this spectrum. Tinted sunscreens containing iron oxides fill that gap. Studies have shown that iron oxide formulations significantly outperform non-tinted mineral SPF 50+ sunscreen at preventing visible light-induced pigmentation in darker skin. They also do double duty by camouflaging existing dark spots while protecting against further darkening.
For best results, apply a broad-spectrum SPF 30 or higher daily, and choose a tinted formula if you have a medium or darker complexion. Reapply every two hours during extended sun exposure.
How Long Treatment Takes
Epidermal PIH (the tan-to-brown type) can take months to years to resolve on its own without treatment. With consistent topical therapy, many people see meaningful fading within 2 to 3 months. Dermal PIH (the blue-gray type) is much more stubborn and may be permanent without professional intervention like peels or laser treatments.
Starting treatment early makes a real difference. The longer pigment sits in the skin, the more it can migrate into deeper layers where it becomes harder to reach. A realistic expectation for most people with epidermal PIH is noticeable improvement by 8 to 12 weeks of consistent treatment, with continued fading over the following months. Dermal involvement extends that timeline considerably, sometimes to a year or more. Patience and consistency with your routine are just as important as the products or procedures you choose.